ACLS vs SRPT · P/E 54, rev $1.02B vs rev $1.90B
Axcelis Technologies Inc (ACLS) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Axcelis Technologies Inc (ACLS) is a semiconductor equipment & materials company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported ACLS revenue for 2024-12-31 was $1.02B. Net income was $201.0M. Revenue was down 10.0% from 2023-12-31 to 2024-12-31. ACLS currently screens at market cap $5.39B and trailing P/E 54.5.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
ACLS currently screens at market cap $5.39B and trailing P/E 54.5. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ACLS and SRPT stock pages for the full models.
Not investment advice.